More on OABI

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+14.3% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (11/17/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

OmniAb (NQ:OABI)
Delayed: 3.99 -0.03 (0.75%)
Prev. Close $4.02  
Open$3.92 
52 Wk High$ 
52 Wk Low$ 
Day High$4.08 
Day Low$3.91 
P/E N/A  
EPS$ 
Volume309,539 

Friends, Peers and Foes (?): CAPR, TECH VACH (more...)

Aug 26, 2026 08:00 AM OmniAb to Participate in Upcoming Investor Conferences
Aug 17, 2026 06:06 AM OmniAb raises 2026 cash guidance on licensing activity
Aug 17, 2026 06:06 AM OmniAb Raises 2026 Financial Guidance
Aug 17, 2026 06:01 AM OmniAb and Eli Lilly reach ion channel drug discovery deal
Aug 17, 2026 06:01 AM OmniAb Announces Global Collaboration and License Agreement for Ion Channel Program with Eli Lilly & Company
Aug 14, 2026 04:50 PM Form SCHEDULE 13G/A OmniAb, Inc. Filed by: Whitefort Capital Management, LP
Aug 6, 2026 04:35 PM Form 10-Q OmniAb, Inc. For: Jun 30
Aug 6, 2026 04:29 PM OmniAb (OABI) Tops Q2 EPS by 7c; Offers Guidance
Aug 6, 2026 04:16 PM Form 8-K OmniAb, Inc. For: Aug 06
Aug 6, 2026 04:05 PM OmniAb Reports Second Quarter 2026 Financial Results and Business Highlights
View All Articles

Entities mentioned with OABI

View All Entities